Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 601–700 of 2,099
Calcium and Redox Liaison: A Key Role of Selenoprotein N in Skeletal Muscle
Zito, E., & Ferreiro, A. (2021) · Cells · doi:10.3390/cells10051116 · Cited by 34
“Skeletal muscle is the main contributor to post-prandial glucose uptake in the body, so defects in musclemediated glucose uptake reduce glucose tolerance and induce insulin resistance [49].”
BackgroundMontgomery, M. K., Bayliss, J. A., Nie, S., Nardo, W. D., Keenan, S. N., Miotto, P. M., Karimkhanloo, H., Huang, C., Schittenhelm, R. B., Don, A. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28889-2 · Cited by 37
Montori-Grau, M., Aguilar-Recarte, D., Zarei, M., Pizarro‐Delgado, J., Palomer, X., & Vázquez‐Carrera, M. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00865-9 · Cited by 34
“Skeletal muscle accounts for most of the insulinstimulated glucose use and, thus, it is the major tissue affected by insulin resistance [3].”
BackgroundPossible role of endostatin in the antiangiogenic therapy of diabetic retinopathy
Behl, T., & Kotwani, A. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.06.017 · Cited by 29
Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance
White, A. T., LaBarge, S. A., McCurdy, C. E., & Schenk, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.05.001 · Cited by 29
Lee, E., Kim, A.-Y., Lee, E. H., Park, J., Park, S., Cho, S., Kim, H. K., Kim, S., & Jeong, K. (2016) · Cell Transplantation · doi:10.3727/096368916x691691 · Cited by 29
Klepochová, R., Valkovič, L., Hochwartner, T., Triska, C., Bachl, N., Tschan, H., Trattnig, S., Krebs, M., & Krššák, M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00300 · Cited by 32
“The main tissue responsible for whole-body energy metabolism, glycogen storage, and glucose uptake, is skeletal muscle (Defronzo et al., 1981; DeFronzo and Tripathy, 2009).”
BackgroundApelin/APJ system: A novel therapeutic target for locomotor system diseases
Luo, J., Liu, W., Feng, F., & Chen, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174286 · Cited by 28
Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes.
Pedersen, A. J. T., Hingst, J. R., Friedrichsen, M., Kristensen, J. M., Højlund, K., & Wojtaszewski, J. F. P. (2015) · Diabetologia · doi:10.1007/s00125-015-3582-z · Cited by 28
“AMPK AMP-activated protein kinase FV(0.1/1.67) Fractional velocity (at 0.1/1.67 mmol/l UDP-glucose) G6P Glucose 6-phosphate GDR Glucose disposal rate GS Glycogen synthase GSK3 Glycogen synthase kinase 3 I-form Glycogen synthase activity independent of G6P NOGD Non-oxidative glucose disposal RM ANOVA Repeated measures…”
BackgroundInfluentialIslam, H., & Gillen, J. B. (2023) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2023.01.002 · Cited by 41
Targeted Bmal1 restoration in muscle prolongs lifespan with systemic health effects in aging model
Gutierrez‐Monreal, M. A., Wolff, C. A., Rijos, E. E., Viggars, M. R., Douglas, C. M., Pagala, V., Peng, J., Hunt, L. C., Ding, H., Huo, Z., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.174007 · Cited by 33
“Changes in inflammatory pathways were also enriched in white fat and liver, and previous studies have shown that maintenance of muscle glucose homeostasis helps prevent chronic inflammation (45, 46).”
Zmynd17 controls muscle mitochondrial quality and whole‐body metabolism
Fujita, R., Yoshioka, K., Seko, D., Suematsu, T., Mitsuhashi, S., Senoo, N., Miura, S., Nishino, I., & Ono, Y. (2018) · The FASEB Journal · doi:10.1096/fj.201701264r · Cited by 30
Fang, L., Guo, J., Wang, Q., Ou, K., Zou, M., Lv, L., Chen, M., & Wang, C. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c04171 · Cited by 27
Takahashi, F., Hashimoto, Y., Kaji, A., Sakai, R., Kawate, Y., Okamura, T., Kondo, Y., Fukuda, T., Kitagawa, N., Okada, H., et al. (2021) · Nutrients · doi:10.3390/nu13072335 · Cited by 33
“However, muscle is a primary organ for glucose metabolism [4], and people with T2DM should maintain Figure 3.”
BackgroundInfluentialVladu, I. M., Forţofoiu, M., Clenciu, D., Forțofoiu, M.-C., Pădureanu, R., Radu, L., Cojan, Ș., Rădulescu, P. M., & Pădureanu, V. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10996 · Cited by 38
“At the level of the skeletal muscle, IR causes a decrease in peripheral glucose utilization, contributing to chronic hyperglycemia and/or hyperinsulinism (10).”
BackgroundClenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells
Meister, J., Bone, D. B. J., Knudsen, J. R., Barella, L. F., Velenosi, T. J., Akhmedov, D., Lee, R. J., Cohen, A. H., Gavrilova, O., Cui, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27540-w · Cited by 33
Guo, W., Zhao, X., Miao, M., Liang, X., Li, X., Qin, P., Lü, J., Zhu, W., Wu, J., Chen, Z., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.883015 · Cited by 34
“During the past few years, skeletal muscle insulin resistance has been considered as an important contributor to metabolic diseases (5).”
BackgroundWang, T., Zheng, L. P., Wang, S., Zhao, M., & Liu, X. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.06.020 · Cited by 30
Mechanisms for the cardiovascular effects of glucagon-like peptide-1
Poudyal, H. (2015) · Acta Physiologica · doi:10.1111/apha.12604 · Cited by 34
“Obesity is characterized by increased circulatory leptin concentrations and leptin resistance in rodents and humans (Maffei et al. 1995, Dagogo-Jack et al. 1996) and type 2 diabetes characterized by increased circulatory insulin concentration and insulin resistance (DeFronzo and Tripathy, 2009).”
BackgroundRuiz‐Alcaraz, A. J., Lipina, C., Petrie, J. R., Murphy, M. J., Morris, A. D., Sutherland, C. D., & Cuthbertson, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056928 · Cited by 30
“Skeletal muscle IR contributes significantly to the metabolic derangements seen in these patients considering that skeletal muscle accounts for the majority of insulin-mediated glucose disposal in the post-prandial state [4].”
BackgroundNuala M Byrne, I. J. H. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000300 · Cited by 28
“Given that muscle insulin resistance is likely the primary driver of progression to type 2 diabetes in this patient population [33], the independent and combined effects of DIWL and different types of EX on body composition and muscle metabolism is clinically relevant and warrants further exploration.”
BackgroundGamelin, F. X., Aucouturier, J., Iannotti, F. A., Piscitelli, F., Mazzarella, E., Aveta, T., Leriche, M., Dupont, E., Cieniewski‐Bernard, C., Montel, V., et al. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0469-5 · Cited by 31
“Regarding the importance of 1) insulin muscle 332 sensitivity during glucose challenge [10], 2) muscle fiber composition on insulin resistance [18] and 3) glucose uptake and 333 insulin sensitivity reduction induced by CB1 activation [22, 23], we can speculate that ECS alteration in muscle mainly 334”
BackgroundPolyol accumulation in muscle and liver in a mouse model of type 2 diabetes
Gallagher, E. J., LeRoith, D., Stasinopoulos, M., Zelenko, Z., & Shiloach, J. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.04.019 · Cited by 32
Peripheral Blood Transcriptomic Signatures of Fasting Glucose and Insulin Concentrations
Chen, B. H., Hivert, M., Peters, M. J., Pilling, L. C., Hogan, J., Pham, L., Harries, L. W., Fox, C. S., Bandinelli, S., Dehghan, A., et al. (2016) · Diabetes · doi:10.2337/db16-0470 · Cited by 39
“This is of particular relevance due to the link between type 2 diabetes and cancer (36) and the role of skeletal muscle in insulin resistance and the development of type 2 diabetes (37).”
BackgroundGalyon, K. D., Farshidi, F., Han, G., Ross, M. G., Desai, M., & Jellyman, J. K. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.08.041 · Cited by 30
André, D. M., Calixto, M. C., Sollon, C. S., Alexandre, E. C., Tavares, E. B. G., Naime, A. C. A., Anhê, G. F., & Antunes, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-17558-w · Cited by 29
Hassanin, K. M. A., Mahmoud, M. O., Hassan, H. M., Abdel‐Razik, A. H., Aziz, L. N., & Rateb, M. E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.167 · Cited by 28
Wang, Y., Li, W., Zhou, S., Zhang, Y., Wang, X.-H., He, Y.-Y., Davie, A. J., & Broadbent, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203551 · Cited by 34
Chen, H., Xiong, L., Wang, N., Liu, X., Hu, W., Yang, Z., Jiang, Y., Zheng, G., Ouyang, K., & Wang, W. (2018) · Food & Function · doi:10.1039/c8fo00954f · Cited by 32
The effects of acute BPA exposure on skeletal muscle mitochondrial function and glucose metabolism
Ahmed, F., Chehadé, L., Garneau, L., Caron, A., & Aguer, C. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110580 · Cited by 30
Penniman, C. M., Beltran, P. A. S., Bhardwaj, G., Junck, T. L., Jena, J., Poro, K., Hirshman, M. F., Goodyear, L. J., & O'Neill, B. T. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.001 · Cited by 30
“Skeletal muscle is the primary site for glucose disposal, and muscle insulin resistance can occur decades before the onset of type 2 diabetes [36].”
BackgroundRoss, L. M., Slentz, C. A., Sudnick, A. M., Huffman, K. M., SHALAUROVA, I. Y., Otvos, J. D., Connelly, M. A., Kraus, V. B., Bales, C. W., Houmard, J. A., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.626142 · Cited by 28
“Insulin resistance is one of the core pathophysiologic contributors to the progression from normoglycemia and/or prediabetes to type 2 diabetes (Defronzo, 2009).”
BackgroundYang, F., Wang, J., Zhang, H., Xie, Y., Jin, J., Liu, H., Pang, X., & Hao, H. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13899 · Cited by 30
Beckerman, M., Harel, C., Michael, I., Klip, A., Bilan, P. J., Gallagher, E. J., LeRoith, D., Lewis, E. C., Karnieli, E., & Levenberg, S. (2021) · Science Advances · doi:10.1126/sciadv.abg3947 · Cited by 28
“The skeletal muscle tissue is responsible for about 80% of infused glucose uptake (5).”
BackgroundWilliams, I. M., & Wasserman, D. H. (2021) · Endocrinology · doi:10.1210/endocr/bqab252 · Cited by 28
Oh, H., Cho, W., El‐Aty, A. M. A., Bayram, C., Jeong, J. H., & Jung, T. W. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115203 · Cited by 28
Chen, R., Zhang, L., Zhang, M., Wang, Y., Liu, D., Li, Z., Zhang, X., Jin, H., Liu, B., & Liu, H. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2128373 · Cited by 28
“the postprandial state [9], and insulin resistance is an”
BackgroundSong, E., Hwang, S. Y., Park, M., Jang, A., Kim, K. J., Yu, J. H., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155678 · Cited by 32
Wu, W., Tang, S., JUNFENG, S., WENWEN, Y., SHU, C., Bu, R., DALONG, Z., & Bi, Y. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2187 · Cited by 30
Hayashi, T., Nozaki, Y., Nishizuka, M., et al. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1257 · Cited by 27
Ouyang, Z., Li, W., Meng, Q., Zhang, Q., Wang, X., Elgehama, A. M., Wu, X., Shen, Y., Sun, Y., Wu, X., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.023 · Cited by 26
Telapolu, S., Kalachaveedu, M., Punnoose, A. M., & Bilikere, D. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2177-x · Cited by 31
“Skeletal muscle and adipose tissue are the primary target site for insulin and play a crucial role in post prandial glucose regulation [39].”
BackgroundAnti-diabetic properties of different fractions of Korean red ginseng
Park, S.-J., Nam, J. S., Ahn, C. W., & Kim, Y.-S. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.01.044 · Cited by 28
Chung, M.-J., Park, S., Son, J.-Y., et al. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1664224 · Cited by 27
Insulin sensitivity depends on the route of glucose administration
Mingrone, G., Panunzi, S., Gaetano, A. D., Ahlin, S., Spuntarelli, V., Bondia‐Pons, I., Barbieri, C., Capristo, E., Gastaldelli, A., & Nolan, J. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05157-w · Cited by 24
AbouAssi, H., Tune, K. N., Gilmore, B. F., Bateman, L. A., McDaniel, G. E., Muehlbauer, M. J., Huebner, J. L., Hoenig, H., Kraus, V. B., Clair, E. W. S., et al. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.140224 · Cited by 29
“36) Adiposity and muscle tissue Abdominal total adipose area, cm2 430 (179) 407 (199) 453 (157) Abdominal subcutaneous adiposity, cm2 306 (144) 302 (149) 309 (141) Abdominal visceral adiposity, cm2 125 (98) 105 (81)† 144 (109) Abdominal liver density, Hu 60 (10) 60 (9) 60 (10) Thigh total area, cm2 254 (65) 253 (69) 2…”
Mouse models of peripheral metabolic disease
Xavier, G. D. S., & Hodson, D. J. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.03.009 · Cited by 30
Heat therapy: possible benefits for cognitive function and the aging brain
Schulze, A. T. V., Deng, F., Morris, J. K., & Geiger, P. C. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00168.2020 · Cited by 29
“The skeletal muscle is the site of 80–85% of glucose disposal during hyperinsulinemic clamp conditions (31), suggesting that these deficits are due to impaired skeletal muscle metabolism.”
BackgroundLi, J., Ding, X., Jian, T., Lv, H., Zhao, L., Li, J., Liu, Y., Ren, B., & Chen, J. (2020) · PeerJ · doi:10.7717/peerj.10413 · Cited by 28
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
Liu, J., Sun, X., Zhang, F.-L., Jin, H., Yan, X., Huang, S., Guo, Z., & Yang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596811 · Cited by 31
Kim, T. J., Lee, H. J., Pyun, D. H., El‐Aty, A. M. A., Jeong, J. H., & Jung, T. W. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114557 · Cited by 27
β-Arrestins as Important Regulators of Glucose and Energy Homeostasis
Pydi, S. P., Barella, L. F., Zhu, L., Meister, J., Rossi, M., & Wess, J. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-060721-092948 · Cited by 25
Song, D. K., Hong, Y. S., Sung, Y., & Lee, H. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00915-2 · Cited by 31
“Because skeletal muscle is the major site of insulin-mediated glucose uptake in the postprandial phase, the defect of skeletal muscle IR was suggested be the pathogenesis of the development of type 2 diabetes [23].”
BackgroundOxidative Stress in Type 2 Diabetes: The Case for Future Pediatric Redoxomics Studies
Alu, S. N., LOS, E. A., Ford, G. A., & Stone, W. L. (2022) · Antioxidants · doi:10.3390/antiox11071336 · Cited by 27
“Skeletal muscle insulin resistance is considered the primary defect in T2D [34].”
BackgroundThe Effects of Asprosin on Exercise-Intervention in Metabolic Diseases
Liu, L., Liu, Y., HUANG, M. L., Zhang, M., Zhu, C., Chen, X., Bennett, S., Xu, J., & Zou, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.907358 · Cited by 33
“Similar to T2DM, asprosin is reported to be positively associated with FBG, HbA1c, HOMA-IR, and testosterone in PCOS (Deniz et al., 2021; Li et al., 2018).”
BackgroundInfluentialYadikar, N., Ahmet, A., Zhu, J., Bao, X., Yang, X., Han, H., & Rozi, P. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14404 · Cited by 27
Bai, W., Zhang, Y., Ma, J., Du, M., Xu, H., Wang, J., Zhang, L., Li, W., Hou, Y., Liu, X., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04680-w · Cited by 27
Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling
Xu, J., Li, X., Chen, W., Zhang, Z., Zhou, Y., Gou, Y., Lv, C.-A., Lu, J., Qiu, X., Ma, S., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221123 · Cited by 29
“As such, impaired glucose sensing and utilization in skeletal muscle commonly feature in the development of obesity-associated metabolic diseases (DeFronzo and Tripathy, 2009; Meng et al., 2017).”
Han, J.-Y., Park, M., & Lee, H. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04033-5 · Cited by 28
Wang, C., Yatsuya, H., Tamakoshi, K., Toyoshima, H., Wada, K., Li, Y., Hilawe, E. H., Uemura, M. Y., Chiang, C., Zhang, Y., et al. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.07.021 · Cited by 31
Brouwer, A., van Raalte, D. H., Diamant, M., Rutters, F., van Someren, E. J. W., Snoek, F. J., Beekman, A. T. F., & Bremmer, M. A. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0543-5 · Cited by 25
“[58].”
Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II
Macconi, D., Perico, L., Longaretti, L., Morigi, M., Cassis, P., Buelli, S., Perico, N., Remuzzi, G., & Benigni, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127172 · Cited by 27
“Skeletal muscle is the major site of insulin-mediated glucose uptake [5, 6] and insulin resistance in this tissue causes metabolic syndrome [7] and is recognized as the initial metabolic defect for the development of type 2 diabetes [8].”
Laurens, C., Badin, P.-M., Louche, K., Mairal, A., Tavernier, G., Marette, A., Tremblay, A., Weisnagel, S. J., Joanisse, D. R., Langin, D., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.04.004 · Cited by 32
“As skeletal muscle acts as a metabolic sink for glucose in postprandial conditions [32,33], impaired insulin action in this organ has an important impact on whole-body glucose homeostasis.”
BackgroundKavanagh, K., Davis, A., Jenkins, K. A., & Flynn, D. M. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0699-z · Cited by 29
Zhang, M., Li, X., Liang, H., Cai, H., Hu, X., Bian, Y., Dong, L., Ding, L., Wang, L., Yu, B., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00235 · Cited by 30
“Insulin resistance in skeletal muscle occurs much earlier before the development of β cell dysfunction and overt hyperglycaemia (DeFronzo and Tripathy, 2009).”
BackgroundBerry, C., Lal, M., & Binukumar, B. K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00210 · Cited by 41
Low serum creatinine predicts risk for type 2 diabetes
Bao, X., Gu, Y., Zhang, Q., Liu, L., Meng, G., Wu, H., Xia, Y., Shi, H., Wang, H., Sun, S., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3011 · Cited by 30
Oza, M. J., & Kulkarni, Y. A. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000019 · Cited by 29
(2012) · PubMed · doi:10.3275/8466 · Cited by 26
“In addition, although this issue is beyond the scope of this review, it is clear that lipid accumulation in adipose tissue, liver, and muscle represents a major abnormality in obesity and diabetes (21), and this is one more reason to target exercise on lipid oxidation.”
BackgroundAccacha, S. D., Barillas, J., Srivastava, A., Ross, F., Drewes, W., Gulkarov, S., Leon, J. D., & Reiss, A. B. (2025) · Metabolites · doi:10.3390/metabo15050287 · Cited by 39
“Insulin resistance is believed to start in the muscle tissue and then adipose tissue [63].”
Nagarajan, V., Gopalan, V., Kaneko, M., Angéli, V., Gluckman, P. D., Richards, M., Kuchel, P. W., & Velan, S. S. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00478.2012 · Cited by 30
“Skeletal muscle is another well-studied organ in diabetes and obesity, as it is the primary organ for glucose disposal in the body (10, 19).”
BackgroundAziz, A. U. R., Farid, S., Qin, K., Wang, H., & Liu, B. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1498903 · Cited by 28
“…(IRSs), IRS-1 and -2, is considered as the most common cause of its genesis on molecular level (Fratantonio et al. 2017, Xin et al. 2017, Zhou et al. 2018), because these substrates are the main targets of insulin receptor tyrosine kinase (Karlsson and Zierath 2007, DeFronzo and Tripathy 2009).”
BackgroundTransendothelial Insulin Transport is Impaired in Skeletal Muscle Capillaries of Obese Male Mice
Williams, I. M., McClatchey, P. M., Bracy, D. P., Bonner, J. S., Valenzuela, F. A., & Wasserman, D. H. (2020) · Obesity · doi:10.1002/oby.22683 · Cited by 23
“Furthermore, SkM is a major site of insulin resistance (IR) during obesity (1, 2) and SkM IR precedes the development of Type 2 diabetes (3).”
BackgroundZhang, X., Xu, D., Chen, M., Wang, Y., He, L., Wang, L., Wu, J. W., & Yin, J. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa161 · Cited by 27
“and glycogen storage in the skeletal muscle (6).”
BackgroundMG53 is not a critical regulator of insulin signaling pathway in skeletal muscle
Philouze, C., Turban, S., Cremers, B., Caliez, A., Lamarche, G., Bernard, C., Provost, N., & Delerive, P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245179 · Cited by 24
Cussonneau, L., Boyer, C., Brun, C., Deval, C., Loizon, E., Meugnier, E., Guéret, É., Dubois, E., Taillandier, D., Polge, C., et al. (2021) · Cells · doi:10.3390/cells10081873 · Cited by 29
Butyrate oxidation attenuates the butyrate-induced improvement of insulin sensitivity in myotubes
Ríos-Morales, M., Vieira‐Lara, M. A., Homan, E., Langelaar‐Makkinje, M., Gerding, A., Zhuang, L., Huijkman, N., Rensen, P. C. N., Wolters, J. C., Reijngoud, D., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166476 · Cited by 29
TBC1D4-S711 Controls Skeletal Muscle Insulin Sensitization After Exercise and Contraction
Kjøbsted, R., Kristensen, J. M., Eskesen, N. O., Kido, K., Fjorder, K., Damgaard, D. F., Larsen, J. K., Andersen, N. R., Birk, J. B., Gudiksen, A., et al. (2023) · Diabetes · doi:10.2337/db22-0666 · Cited by 33
“3 Introduction Progressive deterioration of insulin-stimulated skeletal muscle glucose uptake is a hallmark in the etiology of type 2 diabetes (1).”
BackgroundTargeting the Metabolic Paradigms in Cancer and Diabetes
Bosso, M., Haddad, D., Madhoun, A. S. A., & Al‐Mulla, F. (2024) · Biomedicines · doi:10.3390/biomedicines12010211 · Cited by 30
“In established T2D, insulin resistance arises in peripheral tissues, primarily in the skeletal muscle (SKM) [36], and decreases glucose-induced insulin secretion by pancreatic β cells [37–40].”
BackgroundSkeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: Endocrine aspects
Aguer, C., & Harper, M. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.06.001 · Cited by 31
Skeletal muscle lipid flux: running water carries no poison
Funai, K., & Semenkovich, C. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00152.2011 · Cited by 27
“Skeletal 41 muscle insulin resistance is important in the development of type 2 diabetes (19, 21, 86).”
BackgroundGower, B. A., Alvarez, J. A., Bush, N. C., & Hunter, G. R. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-3 · Cited by 25
“In contrast, AA are disproportionately burdened by type 2 diabetes [36], a disease that results in part from insulin resistance [37].”
BackgroundClark, L. F., Thivierge, M. C., Kidd, C. A., McGeoch, S., Abraham, P., Pearson, D. W. M., Horgan, G. W., Holtrop, G., Thiès, F., & Lobley, G. E. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515004274 · Cited by 25
“2 diabetes is characterised by insulin resistance((2)), and in both people who have developed diabetes and those in a ‘prediabetes’ state altered lifestyle including exercise and/or weight loss can improve glycaemic control.”
BackgroundObanda, D. N., Ribnicky, D., Yu, Y., Stephens, J. M., & Cefalu, W. T. (2016) · Scientific Reports · doi:10.1038/srep22222 · Cited by 34
Role of AMP-Activated Protein Kinase for Regulating Post-exercise Insulin Sensitivity
Kjøbsted, R., Wojtaszewski, J. F. P., & Treebak, J. T. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_5 · Cited by 28
Silva, P. E., Poletto, A. C., David-Silva, A., Seraphim, P. M., Anhê, G. F., Passarelli, M., Furuya, D. T., & Machado, U. F. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0714-8 · Cited by 24
“In the postprandial state, glucose uptake occurs mainly in skeletal muscle [1] through the insulin responsive glucose transporter GLUT4.”
BackgroundElamin, N. M. H., Fadlalla, I. M. T., Omer Shadia, A., & Hala, I. (2018) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410091 · Cited by 41
DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle
Zhang, J., Oh, E., Merz, K. E., Aslamy, A., Veluthakal, R., Salunkhe, V. A., Ahn, M., Tunduguru, R., & Thurmond, D. C. (2019) · Diabetologia · doi:10.1007/s00125-019-4824-2 · Cited by 27
Zheng, Z., Ma, T., Guo, H., Kim, K. S., Kim, K., Bi, L., Zhang, Z., & Cai, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14493 · Cited by 24
Ato, S., Kido, K., Sato, K., & Fujita, S. (2019) · Experimental Physiology · doi:10.1113/ep087585 · Cited by 28
“Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycaemia and insulin resistance (Baron, Brechtel, Wallace, & Edelman, 1988; DeFronzo & Tripathy, 2009).”
BackgroundJayachandran, M., Zhang, T., Wu, Z., Liu, Y., & Xu, B. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05166-y · Cited by 25
Hieshima, K., Sugiyama, S., Yoshida, A., Kurinami, N., Suzuki, T., Ijima, H., MIYAMOTO, F., Kajiwara, K., Jinnouchi, K., Jinnouchi, T., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13191 · Cited by 28
Impact of paternal exercise on physiological systems in the offspring
Neto, I. V. D. S., Fontes, W., Prestes, J., & Marqueti, R. D. C. (2021) · Acta Physiologica · doi:10.1111/apha.13620 · Cited by 25
Insulin Resistance and Insulin Handling in Chronic Kidney Disease
Parvathareddy, V. P., Wu, J., & Thomas, S. S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220019 · Cited by 64
“A balance exists between pancreatic production of insulin and renal elimination of insulin (21, 28, 74).”
Zou, Y.-Y., Chen, Z.-L., Sun, C.-C., Yang, D., Zhou, Z.-Q., Xiao, Q., Peng, X.-Y., & Tang, C.-F. (2022) · Nutrients · doi:10.3390/nu14091975 · Cited by 24
“Furthermore, HFDs can also contribute to metabolic disorders, proinflammatory cytokine expression, and insulin resistance in skeletal muscle [4], the latter of which is one of the primary causes of type 2 diabetes mellitus [5,6].”
BackgroundKaempferol improves glucose uptake in skeletal muscle via an AMPK-dependent mechanism
Moore, W. T., Luo, J., & Liu, D. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.028 · Cited by 27
Kdm2a inhibition in skeletal muscle improves metabolic flexibility in obesity
Wang, Y., Xie, H., Liu, Q., Wang, N., Luo, X., Sun, F., Zhu, J., Dong, R., Wang, Y., Gao, J. L., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01210-9 · Cited by 29
Henagan, T. M. (2014) · Journal of Nutritional Health & Food Science · doi:10.15226/jnhfs.2014.00127 · Cited by 27
“A major site of ectopic lipid deposition and arguably one of the first tissues to exhibit insulin resistance during the onset of type 2 diabetes is skeletal muscle [6].”
BackgroundLee, D. E., Brown, J. L., Rosa, M. E., Brown, L. A., Perry, R. A., Washington, T. A., & Greene, N. P. (2016) · Acta Physiologica · doi:10.1111/apha.12687 · Cited by 30
Sadeghi, A., Shabani, M., Alizadeh, S., & Meshkani, R. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154835 · Cited by 23
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.